Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial
American Heart Journal(2022)
摘要
EMPACT-MI will inform clinical practice regarding the role of empagliflozin in patients after an MI with high risk for the development of future HF and mortality.
更多查看译文
关键词
ACEi,ARNI,ACS,ACS-HF,CV,DMC,HF,HHF,LVEF,LVSD,MI,SGLT2i,T2DM
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要